Ionis Pharmaceuticals
Ionis develops RNA-targeted medicines and gene editing approaches for neurology and cardiometabolic diseases.
10-QNov 12Latest SEC filing
Nov 9Latest story
November 2026
October 2026
September 2026
August 2026
July 2026
Ionis develops RNA-targeted medicines and gene editing approaches for neurology and cardiometabolic diseases.
November 2026
October 2026
September 2026
August 2026
July 2026